Price $4.77 |
Market Cap
51.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
5.9
|
P/B
1.59
|
P/S
0.26
|
Dividend %
2.90%
|
|
P/CF
-
|
P/FCF
4.7
|
Op. Cash Flow
13.6K
|
FCF
0.8
|
|
Op. Margin
6.00%
|
Net Margin
4.50%
|
ROE
26.40%
|
ROI
36.10%
|
|
ROA
12.60%
|
EPS Growth
-16.20%
|
Current Ratio
1.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Soligenix Inc (SNGX) | $0.60 | - | - | 24.8M | Strong Buy |
| Compugen Ltd. (USA) (CGEN) | $2.09 | - | - | 159.9M | Strong Buy |
| Clearside Biomedical Inc (CLSD) | $1.65 | - | - | 78.2M | Strong Buy |
| Repro-Med Systems, Inc. (KRMD) | $2.43 | - | - | 98.3M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $0.65 | - | - | 22.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
